Growth Mindset Psychoeducation for Modifiable Risk Factors for CMD

NCT ID: NCT03707522

Last Updated: 2019-08-12

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

162 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-06-19

Study Completion Date

2018-12-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study aims to determine the effect of presenting psychoeducation emphasizing "growth-mindset," and information on modifiable risk factors (e.g., social contact, physical activity) on engagement with modifiable risk factors. The investigators hypothesize that psychoeducation emphasizing that mental health is malleable will increase the participant's engagement with risk factors outlined in the intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression, Anxiety

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Growth mindset + MRF Information

Online growth mindset interactive article followed by equal length interactive article describing the relationship between modifiable risk factors (MRF) and mental health outcomes

Group Type EXPERIMENTAL

Growth mindset

Intervention Type BEHAVIORAL

10 minute interactive article describing neuroplasticity

Modifiable risk factor (MRF) information

Intervention Type BEHAVIORAL

10 minute interactive article describing modifiable risk factors for depression and anxiety

Control + MRF information

Online daily activity scheduling interactive article (control) followed by equal length interactive article describing the relationship between modifiable risk factors and mental health outcomes

Group Type EXPERIMENTAL

Modifiable risk factor (MRF) information

Intervention Type BEHAVIORAL

10 minute interactive article describing modifiable risk factors for depression and anxiety

Control

Intervention Type BEHAVIORAL

10 minute interactive article describing activity scheduling

Control + Growth mindset

Online growth mindset interactive article followed by equal length online daily activity scheduling interactive article (control)

Group Type EXPERIMENTAL

Growth mindset

Intervention Type BEHAVIORAL

10 minute interactive article describing neuroplasticity

Control

Intervention Type BEHAVIORAL

10 minute interactive article describing activity scheduling

Control + Control

2 doses online daily activity scheduling interactive article (control)

Group Type PLACEBO_COMPARATOR

Control

Intervention Type BEHAVIORAL

10 minute interactive article describing activity scheduling

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Growth mindset

10 minute interactive article describing neuroplasticity

Intervention Type BEHAVIORAL

Modifiable risk factor (MRF) information

10 minute interactive article describing modifiable risk factors for depression and anxiety

Intervention Type BEHAVIORAL

Control

10 minute interactive article describing activity scheduling

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* College freshmen

Exclusion Criteria

* Not fluent in English
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Nevada, Reno

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Martha Zimmermann

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anthony Papa, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Nevada, Reno

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Nevada, Reno

Reno, Nevada, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med. 1997;4(1):92-100. doi: 10.1207/s15327558ijbm0401_6.

Reference Type BACKGROUND
PMID: 16250744 (View on PubMed)

Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.

Reference Type BACKGROUND
PMID: 11556941 (View on PubMed)

Lee JP, Lee RM, Hu AW, Kim OM. Ethnic Identity as a Moderator against Discrimination for Transracially and Transnationally Adopted Korean American Adolescents. Asian Am J Psychol. 2015 Jun;6(2):154-163. doi: 10.1037/a0038360.

Reference Type BACKGROUND
PMID: 26273427 (View on PubMed)

Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092.

Reference Type BACKGROUND
PMID: 16717171 (View on PubMed)

Zazpe I, Bes-Rastrollo M, Ruiz-Canela M, Sanchez-Villegas A, Serrano-Martinez M, Martinez-Gonzalez MA. A brief assessment of eating habits and weight gain in a Mediterranean cohort. Br J Nutr. 2011 Mar;105(5):765-75. doi: 10.1017/S0007114510004149. Epub 2010 Dec 8.

Reference Type BACKGROUND
PMID: 21138604 (View on PubMed)

Ottenbreit ND, Dobson KS. Avoidance and depression: the construction of the cognitive-behavioral avoidance scale. Behav Res Ther. 2004 Mar;42(3):293-313. doi: 10.1016/S0005-7967(03)00140-2.

Reference Type BACKGROUND
PMID: 14975771 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Psychoeducation for CMD

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mechanisms of Cognitive Change
NCT04103775 TERMINATED NA